Drug Profile
Ursodeoxycholic acid - Travere Therapeutics
Alternative Names: L-UDCA; liquid formulation ursodeoxycholic acid; ursodeoxycholic acid liquidLatest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator Asklepion Pharmaceuticals
- Developer Retrophin
- Class Cholic acids; Gallstone therapies; Hepatoprotectants; Small molecules
- Mechanism of Action Cholesterol inhibitors; Immunomodulators; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Primary biliary cirrhosis